Researchers Elif Kaya Tilki
Elif Kaya Tilki profile image
Elif Kaya Tilki Asst. Prof. Dr. ANADOLU ÜNİVERSİTESİ, ECZACILIK FAKÜLTESİ, ECZACILIK MESLEK BİLİMLERİ BÖLÜMÜ, FARMAKOLOJİ ANABİLİM DALI
Publication 1 Review 3
1 Publication
3 Review

Research Fields

Clinical Pharmacology and Therapeutics Basic Pharmacology Medical Pharmacology

Institution

ANADOLU ÜNİVERSİTESİ, ECZACILIK FAKÜLTESİ, ECZACILIK MESLEK BİLİMLERİ BÖLÜMÜ, FARMAKOLOJİ ANABİLİM DALI

Publications

The proteasome inhibitor ixazomib targets epigenetic chromatin modification enzymes upregulated by m2c macrophage polarisation in lung cancer
Authors: Elif Kaya Tilki , Selin Engür Öztürk
Published: 2024 , İstanbul Journal of Pharmacy
DOI: 10.26650/IstanbulJPharm.2024.1336667
FAVORITE 0 TOTAL DOWNLOAD COUNT 13

0

13

Articles published in
İstanbul Journal of Pharmacy
İstanbul Journal of Pharmacy

Reviews

Clinical and Experimental Health Sciences
Clinical and Experimental Health Sciences
Eskişehir Teknik Üniversitesi Bilim ve Teknoloji Dergisi - C Yaşam Bilimleri Ve Biyoteknoloji
Eskişehir Teknik Üniversitesi Bilim ve Teknoloji Dergisi - C Yaşam Bilimleri Ve Biyoteknoloji
Online Turkish Journal of Health Sciences
Online Turkish Journal of Health Sciences
There are no Crossref cited.
Popular Publications: It is determined automatically by the researchers doing research in DergiPark according to the statistics of being added to the favorites. CrossRef Cited: The citations shown in DergiPark are drawn from CrossRef. For this, the cited and cited articles must be registered in CrossRef (DOI number). ^: Citation numbers are reflected in the system by DergiPark at certain periods.
Interactive Guide Tool
If you want to see the panel introduction, you can click Start Tour.